Latest news
Gilead Earnings: HIV Prevention Market Growth Drives Strong Quarter, Maintaining Our Fair Value - MorningstarMorningstar · Wed, 05 Aug 2026 08:12:06 GMTAmgen Earnings: Broad-Based Growth Despite Prolia Biosimilars; Maintaining Our Fair Value - MorningstarMorningstar · Wed, 05 Aug 2026 06:56:12 GMTJP Morgan: Maintaining our Existing USD/JPY 160-164 Targets Post Coordinated Intervention - eFXdataeFXdata · Tue, 04 Aug 2026 13:29:43 GMTTransUnion Results: Encouraging Quarter; Maintaining Our $85 Fair Value Estimate - MorningstarMorningstar · Tue, 28 Jul 2026 20:40:16 GMTS&P Global Earnings: Messy but Decent Quarter; Maintaining Our $505 Fair Value Estimate - MorningstarMorningstar · Tue, 28 Jul 2026 07:00:00 GMT